Literature DB >> 34203192

Dysregulation of Blood-Brain Barrier and Exacerbated Inflammatory Response in Cx47-Deficient Mice after Induction of EAE.

Filippos Stavropoulos1, Elena Georgiou1, Irene Sargiannidou1, Kleopas A Kleopa1,2.   

Abstract

Induction of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), in connexin 32 (Cx32) or Cx47 knockout (KO) mice with deficiency in oligodendrocyte gap junctions (GJs) results in a more severe disease course. In particular, Cx47 KO EAE mice experience an earlier EAE onset and more pronounced disease severity, accompanied by dysregulated pro-inflammatory responses preceding the disease manifestations. In this study, analysis of relevant pro-inflammatory cytokines in wild type EAE, Cx32 KO EAE, and Cx47 KO EAE mice revealed altered expression of Vcam-1 preceding EAE [7 days post injection (dpi)], of Ccl2 at the onset of EAE (12 dpi), and of Gm-csf at the peak of EAE (24 dpi) in Cx47 KO EAE mice. Moreover, Cx47 KO EAE mice exhibited more severe blood-spinal cord barrier (BSCB) disruption, enhanced astrogliosis with defects in tight junction formation at the glia limitans, and increased T-cell infiltration prior to disease onset. Thus, Cx47 deficiency appears to cause dysregulation of the inflammatory profile and BSCB integrity, promoting early astrocyte responses in Cx47 KO EAE mice that lead to a more severe EAE outcome. Further investigation into the role of oligodendrocytic Cx47 in EAE and multiple sclerosis pathology is warranted.

Entities:  

Keywords:  astrocytes; connexins; cytokines; experimental autoimmune encephalomyelitis; glio-vascular interface; multiple sclerosis; oligodendrocytes

Year:  2021        PMID: 34203192     DOI: 10.3390/ph14070621

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  71 in total

1.  The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis.

Authors:  Armin Schneider; Carola Krüger; Tobias Steigleder; Daniela Weber; Claudia Pitzer; Rico Laage; Jaroslaw Aronowski; Martin H Maurer; Nikolaus Gassler; Walter Mier; Martin Hasselblatt; Rainer Kollmar; Stefan Schwab; Clemens Sommer; Alfred Bach; Hans-Georg Kuhn; Wolf-Rüdiger Schäbitz
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

2.  Astrocytic dye coupling in rat hippocampus: topography, developmental onset, and modulation by protein kinase C.

Authors:  U Konietzko; C M Müller
Journal:  Hippocampus       Date:  1994-06       Impact factor: 3.899

3.  Hematopoietic growth factors pass through the blood-brain barrier in intact rats.

Authors:  Li-Ru Zhao; Yot Navalitloha; Seema Singhal; Jayesh Mehta; Chun-Shu Piao; Wen-Ping Guo; John A Kessler; Dennis R Groothuis
Journal:  Exp Neurol       Date:  2007-02-20       Impact factor: 5.330

4.  Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.

Authors:  Kyriaki Markoullis; Irene Sargiannidou; Natasa Schiza; Andreas Hadjisavvas; Federico Roncaroli; Richard Reynolds; Kleopas A Kleopa
Journal:  Acta Neuropathol       Date:  2012-04-07       Impact factor: 17.088

5.  Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.

Authors:  Don Mahad; Melissa K Callahan; Katherine A Williams; Eroboghene E Ubogu; Pia Kivisäkk; Barbara Tucky; Grahame Kidd; Gillian A Kingsbury; Ansi Chang; Robert J Fox; Matthias Mack; M Bradley Sniderman; Rivka Ravid; Susan M Staugaitis; Monique F Stins; Richard M Ransohoff
Journal:  Brain       Date:  2005-10-17       Impact factor: 13.501

6.  Cx47 fine-tunes the handling of serum lipids but is dispensable for lymphatic vascular function.

Authors:  Merlijn J Meens; Issa Kutkut; Viviane Rochemont; Juan Dubrot; Fouad R Kaladji; Amélie Sabine; Oliver Lyons; Stefanie Hendrikx; Jeremiah Bernier-Latmani; Friedemann Kiefer; Alberto Smith; Stéphanie Hugues; Tatiana V Petrova; Brenda R Kwak
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

7.  Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.

Authors:  M V Jones; T T Nguyen; C A Deboy; J W Griffin; K A Whartenby; D A Kerr; P A Calabresi
Journal:  J Neuroimmunol       Date:  2008-06-25       Impact factor: 3.478

8.  Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17).

Authors:  Kyle J Garton; Peter J Gough; Julie Philalay; Paul T Wille; Carl P Blobel; Robert H Whitehead; Peter J Dempsey; Elaine W Raines
Journal:  J Biol Chem       Date:  2003-07-23       Impact factor: 5.157

9.  Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1.

Authors:  K J Kennedy; R M Strieter; S L Kunkel; N W Lukacs; W J Karpus
Journal:  J Neuroimmunol       Date:  1998-12-01       Impact factor: 3.478

10.  CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis.

Authors:  B T Fife; G B Huffnagle; W A Kuziel; W J Karpus
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

View more
  3 in total

1.  Beneficial Effect of Melatonin Alone or in Combination with Glatiramer Acetate and Interferon β-1b on Experimental Autoimmune Encephalomyelitis.

Authors:  Genaro Gabriel Ortíz; Ana Laura Briones-Torres; Gloria Benitez-King; Luis Javier González-Ortíz; Claudia Verónica Palacios-Magaña; Fermín Paul Pacheco-Moisés
Journal:  Molecules       Date:  2022-06-30       Impact factor: 4.927

Review 2.  Cytokines in the Brain and Neuroinflammation: We Didn't Starve the Fire!

Authors:  Jan Pieter Konsman
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-25

3.  Design of Oral Sustained-Release Pellets by Modeling and Simulation Approach to Improve Compliance for Repurposing Sobrerol.

Authors:  Chu-Hsun Lu; Yu-Feng Huang; I-Ming Chu
Journal:  Pharmaceutics       Date:  2022-01-11       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.